Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine-driven inflammation and fibrosis. - Wikidata - awgldk - TriplyDB

Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine-driven inflammation and fibrosis.

Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine-driven inflammation and fibrosis.

http://www.wikidata.org/entity/Q40687007

about

Extracellular Vesicles from a Helminth Parasite Suppress Macrophage Activation and Constitute an Effective Vaccine for Protective Immunity The Role of Innate Lymphoid Cells in Immune-Mediated Liver Diseases.Epithelial Cell Regulation of Allergic Diseases.Accurately measuring and modeling Th2 and Th17 endotypes in severe asthma The atopic march: current insights into skin barrier dysfunction and epithelial cell-derived cytokines.Spontaneous Chitin Accumulation in Airways and Age-Related Fibrotic Lung Disease.Interleukin-33 in health and disease.Liver macrophages in tissue homeostasis and disease.Are ILC2s Jekyll and Hyde in airway inflammation?Interplay between barrier epithelial cells and dendritic cells in allergic sensitization through the lung and the skin.New perspectives on the regulation of type II inflammation in asthma.Type 2 immunity in tissue repair and fibrosis.IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation.Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma.Interleukin-25 primed mesenchymal stem cells achieve better therapeutic effects on dextran sulfate sodium-induced colitis via inhibiting Th17 immune response and inducing T regulatory cell phenotype.Interleukin-33 in the pathogenesis of liver fibrosis: alarming ILC2 and hepatic stellate cells.Toll-Like Receptor 4, but Not Neutrophil Extracellular Traps, Promote IFN Type I Expression to Enhance Th2 Responses to Nippostrongylus brasiliensis.Pathological and therapeutic roles of innate lymphoid cells in diverse diseases.Cell Type-Specific Immunomodulation Induced by Helminthes: Effect on Metainflammation, Insulin Resistance and Type-2 Diabetes.Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin-driven IL-9+ and IL-13+ type 2 innate lymphoid cell subpopulations.Targeting cytokines in asthma therapy: could IL-37 be a solution?Down-regulation of microRNA-203-3p initiates type 2 pathology during schistosome infection via elevation of interleukin-33.Role of alarmin cytokines and microRNAs in the host-schistosome interaction Helminth Infections Induce Tissue Tolerance Mitigating Immunopathology but Enhancing Microbial Pathogen Susceptibility Schistosoma "Eggs-Iting" the Host: Granuloma Formation and Egg Excretion

P2860

Q33759040-9973585B-8375-4A09-B930-66663D2C2102 Q33790954-6F8038B7-E6D0-4BE9-9DEF-14DD4AF5DB7E Q34537698-06B9C3CF-5EEB-4197-AA5A-0E81910F8387 Q37680778-2E9AE52F-65A7-44DC-85D1-6CDF38C90B38 Q38704374-464118AF-9667-48F5-BCC4-A578E16637FA Q38826346-F9492E49-9AE4-4282-801C-CAE75AE9E02A Q38957840-EFD4B50D-4484-4FF2-8CB8-C6EC0BB30A91 Q39187324-E6154A79-D2CB-4F32-B4F6-75BB20539749 Q39402910-48254CDA-D808-404D-A1AB-8AB637CC44E6 Q39402927-B309C6F7-C84C-4FA2-8A1D-72AA893FEAA8 Q39442990-10E857BF-6CC0-40F5-AD78-84B7BC6B1DFD Q40074887-2985B74E-787E-4EF7-8E44-BBD5D5B7049E Q40172237-EC9D0AD1-783E-4F37-A3A4-507D22CFC81C Q41810080-0F255062-CD02-4BBA-9696-B366383790A3 Q42030296-515D90EB-7F63-4A4E-BB13-699D7334877A Q45863196-C2537BC0-78B0-4BFD-9D3F-2FEAAA50CFC1 Q47095345-24DA484F-429B-4DD8-8DC1-7375AD1C5D84 Q47897160-94AECDFC-02C3-4C39-9EC3-AD48DF89E1D5 Q49989611-4CCD1F84-1A18-4CB2-AAEE-D7DB9FCD3C2D Q50044309-7A94BD0C-BD8C-4604-B6C5-CF9F0190C94A Q54169770-184ADBA7-C775-4674-B10B-A8D79EE56063 Q54253472-AB796465-D1CC-496A-8AF9-0E8133F9C780 Q57821009-ABC64043-2D9C-4403-BD91-652075B5EBDA Q58553829-A0F56C33-11F5-401B-BAE9-E6B860E8591E Q59127674-BBF1DBCD-3B34-4BA7-BF59-A044B32A223D

P2860

Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine-driven inflammation and fibrosis.

http://www.wikidata.org/entity/Q40687007

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Combinatorial targeting of TSL ...... ven inflammation and fibrosis.

@en

type

label

Combinatorial targeting of TSL ...... ven inflammation and fibrosis.

@en

prefLabel

Combinatorial targeting of TSL ...... ven inflammation and fibrosis.

@en

P1433

Q40687007-F7F670D3-5CED-4148-9625-09285F17F1DF

P1476

Q40687007-4F5D99C3-38F3-4244-8149-2067B9389282

P2093

Q40687007-04930363-D17C-488F-9FEC-CBD73451B7FB

Q40687007-149ECE76-0BFA-4996-829C-37B57D459C20

Q40687007-1ED464F9-E738-4CDD-9AC1-6DDA2CAA358C

Q40687007-43DFDDAF-C42C-477D-91A0-63FCD42AC464

Q40687007-601823C7-ACD2-4AC5-AE96-6B3CD9A405BA

Q40687007-6B69E317-ED1E-481D-9C80-C2AB35356188

Q40687007-9C9A10A6-2D04-46B1-913C-E37A2205786E

Q40687007-AEC6AE02-090A-4BD6-B594-0DA9EA79AAB3

Q40687007-BD6B8EE9-C527-44EF-835D-73CCA7334ECC

Q40687007-BDB5553F-1A9F-4348-975B-E77CCD6B7E64

P2860

Q40687007-01648A75-D32E-4FA5-91F9-337DD69AE362

Q40687007-01CD88C7-EFC0-4EC6-8320-66CCB2EECDD4

Q40687007-02BEE6AA-DBAE-45EC-8656-46EB9778BBF2

Q40687007-03C87491-0358-444A-BFF7-EABFD9FEA5F3

Q40687007-0A9F6E7F-EDCD-4D5C-9DA5-2A945E82A8B7

Q40687007-0CFD1210-42AE-44DE-8B60-AA5F4FB14F90

Q40687007-17EFE699-0B3A-4D66-A95C-6F8A3FCDA5A2

Q40687007-1ED1490C-86CA-4E65-9C8B-8CD486F1945F

Q40687007-21E027F0-F0C3-4103-98AB-B4B1E2D3F552

Q40687007-26D8B58A-CF28-4150-97B4-C4934D89CC7E

P304

Q40687007-F1996409-3655-4350-8078-FEDE739DF97D

P31

Q40687007-60D24275-BA91-4BC4-A46F-F411FC9B1266

P356

Q40687007-90067F01-9788-4654-9CC3-5F298C31F7DB

P407

Q40687007-2B826158-8F20-444D-A34F-158D09991EC6

P433

Q40687007-F722A9BA-85CD-48B5-B7D4-9805CB973C74

P478

Q40687007-36B92BA0-6F2A-48AC-9C85-E9D617190A6D

P577

Q40687007-777BC5F0-E560-4DFA-A32E-8BC04072EE8F

P698

Q40687007-1F86C3ED-AEB7-4B49-B828-593D9AD2C4C2

P356

SCITRANSLMED.AAF1938

P1433

Science Translational Medicine

P1476

Combinatorial targeting of TSL ...... ven inflammation and fibrosis.

@en

P2093

Alison L Budelsky

http://www.w3.org/2001/XMLSchema#string

Allen W Cheever

http://www.w3.org/2001/XMLSchema#string

Dirk E Smith

http://www.w3.org/2001/XMLSchema#string

Kevin M Hart

http://www.w3.org/2001/XMLSchema#string

Kevin M Vannella

http://www.w3.org/2001/XMLSchema#string

Kristen N Kindrachuk

http://www.w3.org/2001/XMLSchema#string

Lee A Borthwick

http://www.w3.org/2001/XMLSchema#string

Luke Barron

http://www.w3.org/2001/XMLSchema#string

Michael R Comeau

http://www.w3.org/2001/XMLSchema#string

Robert W Thompson

http://www.w3.org/2001/XMLSchema#string

P2860

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract

Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion

IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo

IL-33, a potent inducer of adaptive immunity to intestinal nematodes

Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities

Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice

IL-25 drives remodelling in allergic airways disease induced by house dust mite

Functional diversity of helper T lymphocytes

P304

337ra65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.AAF1938

http://www.w3.org/2001/XMLSchema#string

P407

P433

337

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27147589

http://www.w3.org/2001/XMLSchema#string